Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7591 | 1270 | 35.5 | 88% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3021 | 2041 | GLASGOW PROGNOSTIC SCORE//NEUTROPHIL TO LYMPHOCYTE RATIO//NEUTROPHIL LYMPHOCYTE RATIO |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GLASGOW PROGNOSTIC SCORE | Author keyword | 151 | 90% | 5% | 65 |
2 | NEUTROPHIL TO LYMPHOCYTE RATIO | Author keyword | 53 | 45% | 7% | 89 |
3 | NEUTROPHIL LYMPHOCYTE RATIO | Author keyword | 44 | 43% | 6% | 78 |
4 | INFLAMMATION BASED PROGNOSTIC SCORE | Author keyword | 27 | 92% | 1% | 11 |
5 | PLATELET LYMPHOCYTE RATIO | Author keyword | 21 | 57% | 2% | 25 |
6 | PLATELET TO LYMPHOCYTE RATIO | Author keyword | 18 | 58% | 2% | 21 |
7 | PROGNOSTIC NUTRITIONAL INDEX | Author keyword | 17 | 72% | 1% | 13 |
8 | MGPS | Author keyword | 15 | 77% | 1% | 10 |
9 | MODIFIED GLASGOW PROGNOSTIC SCORE | Author keyword | 11 | 100% | 0% | 6 |
10 | GLASGOW PROGNOSTIC SCORE GPS | Author keyword | 8 | 100% | 0% | 5 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PREOPERATIVE NEUTROPHIL | 79 | 72% | 5% | 63 |
2 | NEUTROPHIL LYMPHOCYTE RATIO | 65 | 48% | 8% | 99 |
3 | NEUTROPHIL LYMPHOCYTE | 61 | 95% | 2% | 20 |
4 | PRETREATMENT NEUTROPHIL | 59 | 81% | 3% | 35 |
5 | PREOPERATIVE ELEVATION | 44 | 73% | 3% | 33 |
6 | ELEVATED PREOPERATIVE NEUTROPHIL | 35 | 86% | 1% | 18 |
7 | LYMPHOCYTE RATIO | 29 | 30% | 6% | 82 |
8 | SYSTEMIC INFLAMMATORY RESPONSE | 24 | 13% | 14% | 172 |
9 | SCORE GPS | 19 | 80% | 1% | 12 |
10 | TO LYMPHOCYTE RATIO | 19 | 43% | 3% | 34 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis | 2014 | 26 | 104 | 78% |
The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer | 2013 | 73 | 63 | 90% |
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer | 2013 | 81 | 73 | 82% |
Prognostic role of neutrophil- to- lymphocyte ratio in colorectal cancer: A systematic review and meta- analysis | 2014 | 29 | 37 | 57% |
A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours | 2014 | 15 | 58 | 79% |
Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis | 2014 | 15 | 44 | 59% |
Prognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer: a systemic review and meta-analysis | 2015 | 1 | 24 | 63% |
Role of systemic inflammatory response in predicting survival in patients with primary operable cancer | 2010 | 188 | 119 | 64% |
Immunomonitoring and prognostic relevance of neutrophils in clinical trials | 2013 | 35 | 61 | 56% |
The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis | 2014 | 8 | 26 | 62% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UNIT GENET EPIDEMIOL PHARMACOGENET | 7 | 53% | 0.8% | 10 |
2 | WEST SCOTLAND COLORECTAL CANC MANAGED CLIN NETWOR | 4 | 75% | 0.2% | 3 |
3 | GEORGE W COMSTOCK PUBL HLTH PREVENT | 2 | 36% | 0.4% | 5 |
4 | BIOMED PHYSIOPATHOL OBES NUTR CIBER CB0 | 2 | 67% | 0.2% | 2 |
5 | WEST SCOTLAND CANC SURVEILLANCE UNIT | 2 | 29% | 0.5% | 6 |
6 | CLIN RADIOTHER EUT ONCOL | 1 | 100% | 0.2% | 2 |
7 | HLTH BEHAV SCI HLTH EDUC | 1 | 100% | 0.2% | 2 |
8 | JIANGMEN CITY CENT HOSP | 1 | 50% | 0.2% | 2 |
9 | LD MCLEAN SURG S | 1 | 50% | 0.2% | 2 |
10 | OVARIAN CANC ACT HHMT UNIT | 1 | 50% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000098830 | NEUTROPHIL TO LYMPHOCYTE RATIO//LEUKOCYTE COUNT//WHITE BLOOD CELL COUNT |
2 | 0.0000092735 | THROMBOCYTOSIS//TCIPA//TUMOR CELL INDUCED PLATELET AGGREGATION |
3 | 0.0000073867 | TUMOR ASSOCIATED MACROPHAGES//TUMOR ASSOCIATED MACROPHAGE//TUMOUR ASSOCIATED MACROPHAGES |
4 | 0.0000072103 | FOXP3//TUMOR INFILTRATING LYMPHOCYTES//INTEGRAT CANC IMMUNOL |
5 | 0.0000064312 | UNIT IMMUNOMICROBIO ENVIRONM CARCINOGENESIS//ANTI INTERLEUKIN 6 ANTIBODY//AUTOCRINE AND PARACRINE LOOPS |
6 | 0.0000051360 | G CSF PRODUCING TUMOR//LEUKEMOID REACTION//LEUKOCYTOSIS |
7 | 0.0000049419 | MORPH ANAL GRP//CORE MUSCLE SIZE//INTRAMUSCULAR ADIPOSE TISSUE CONTENT |
8 | 0.0000046935 | MYELOID DERIVED SUPPRESSOR CELLS//MDSC//MYELOID DERIVED SUPPRESSOR CELL |
9 | 0.0000044880 | CANCER CACHEXIA//CACHEXIA//PROTEOLYSIS INDUCING FACTOR |
10 | 0.0000044478 | RENAL CELL//RADICAL NEPHRECTOMY//FUHRMAN GRADING |